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Table.
Ruptured VAA (N ¼ 69) No. (%)
Gender (Male) 43 (62.3)
Age (mean)6SD 5S.8 6 15
Smoking 16 (23.2)
VAA type (pseudoaneurysm) 55 (79.7)
Mean size (mm) (range) 20.5 (3.5-75)
Splenic 19 (27.5)
Celiac 6 (8.7)
SMA 8 (11.6)
Hepatic 16 (23.2)
Renal 1 (1.5)
Pancreaticoduodenal (PDA) 18 (26.1)
Comorbidities
DM 8 (11.6)
CRI 6 (8.7)
ESRD 1 (1.4)
Hypertension 41 (59.4)
Hyperlipidemia 13 (18.8)
CAD 4 (5.9)
COPD 7 (10.1)
CVA 5 (7.2)
Pancreatitis 29 (42)
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Objectives: Most prior single-center series have rec-
ommended repair of asymptomatic renal artery aneurysms
(RAA) >2 cm. This study evaluated the contemporary
management of a large series of RAAs.
Methods: PatientswithRAAswereanalyzedusinga stan-
dardized database by a research consortium of 15 institutions.
Results: A total of 614 RAAs were identiﬁed in 525 pa-
tients at 15 institutions (age, 61; male-to-female ratio ¼
1:2). Seventy-one percent of patients were asymptomatic.
Symptomatic patients had severe hypertension (12%), ﬂank
pain (7%), abdominal pain (6%), and hematuria (4%). Aneu-
rysm location included the main renal artery bifurcation
(40%), main trunk (28%), primary branch (18%), secondary
branch (7%), and pole artery (7%). Most RAAs were saccular
(86%) and calciﬁed (64%). Diameters were 1.86 0.1 cm for
symptomatic RAAs and 1.5 6 0.1 cm for asymptomatic
RAAs (P< .001). Aneurysms were observed (67%; diameter
1.3 6 .1 cm) or surgically treated with open repair (OR;
28%; diameter 2.1 6 .1 cm), or endovascularly (EV; 5%;
diameter 2.36 .2 cm). For OR vs EV, minor complications
were 26% and 10%, respectively (P< .001), and major com-
plications were 1% and 3%, respectively (P ¼ .014). Only
one death occurred, in an EV patient. Conservatively
managed patients were observed for 41 6 4 months with
no ruptures. Fifty-nine RAA >2 cm were treated non-OR
(diameter 2.8 6 .1 cm) with a mean follow-up time of 42
6 10 months. There were no ruptures. The growth rate
for asymptomatic RAA, based on serial imaging, was 0.16
6 0.01 cm/y (calciﬁed ¼ 0.16 6 0.01 cm/y; noncalciﬁed
¼ 0.17 6 0.01 cm/y; P ¼ .913).
Conclusions: This largest study of RAA demonstrates
that (1) asymptomatic RAA rarely rupture, even when >2
cm and not calciﬁed, (2) open repair is associated with signif-
icantminormorbidity but rarely amajormorbidity ormortal-
ity, (3)RAAgrowth rate is 0.1660.01 cm/yandcalciﬁcation
does not protect against growth, (4) the current guideline of
repairing asymptomatic RAA >2 cm is too aggressive.
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Objectives: To review the outcomes of open and
endovascular intervention for intact visceral artery aneu-
rysm (iVAA) and ruptured VAA (rVAA).
Methods: Retrospective review of treated VAA at one
institution from 2003 to 2013.
Results: We identiﬁed 261patients with VAA; of these
155 were repaired (69 ruptured, 86 intact; Table). Pseudo-
aneurysms were more common in rVAA (80%) vs iVAA
(35%; P < .001). rVAA were smaller than iVAA (20.5 vs
27.5mm;P¼ .018) at repair, and theirmost commonpresen-
tation was abdominal pain; 18% were hemodynamically un-
stable. Endovascular intervention was the initial treatment
for 70% (78% for rVAA, 63% for iVAA). Perioperative compli-
cation rate was higher for rVAA (19% vs iVAA 4%; P¼ .003),
as well as 30-day (12% vs 0% iVAA; P¼ .001), 1-year (26% vs
4% iVAA; P< .001), and 3-year (30% vs 7% iVAA; P< .001)
mortality.Lower30-daymortalitywasnotedwith endovascu-
lar repair for rVAA (7% vs 28% open; P ¼ .06). Predictors of
mortality for rVAA included age (HR, 1.098; P ¼ .006)
whereas endovascular repair was protective (HR, 0.231;
P¼ .035).Mean followupwas26months, andKaplan-Meier
estimates of survival were higher for iVAA at 3 years (88% vs
62% iVAA, P ¼ .045). The 30-day reintervention rate was
higher for rVAA (9% vs 1% iVAA; P ¼ .045), but was similar
betweenopenand endovascular repair (8.5%vs15%,P¼NS).
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or endovascular interventions are equally durable, but endo-
vascular interventions for rVAA result in lowermorbidity and
mortality. Aggressive treatment of pseudoaneurysms is elec-
tively recommended at diagnosis, regardless of size.
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Background: Endovascular therapy for treating com-
plex thoracoabdominal aortic dissections with aneurysmal
degeneration is riddled with challenges of inadequate false
lumen exclusion and thrombosis, inadequate proximal and
distal landing zones with septum dividing the true and false
lumen, and thepotential for visceralmalperfusion.Thismovie
presentation will focus on a stepwise approach to managing
complex thoracoabdominal dissections and aneurysms with
advanced imaging, thoracic endovascular aortic repair
(TEVAR), endovascular aneurysm repair (EVAR), in situ fen-
estrations, endovascular septectomy, and chimneys as neces-
sary adjunctive techniques for successful thoracoabdominal
dissection and aneurysm exclusion and visceral perfusion.
Technical description: Patient presented with chronic
thoracoabdominal aortic dissection from left subclavian to
iliac bifurcation with 6.5-cm thoracic aneurysm and 6-cm
abdominal aortic aneurysm (AAA). Underwent TEVAR
and false lumen coil embolization for complete false lumen
exclusion. EVAR was planned several months later. The
juxtarenal and infrarenal aorta had a chronic aortic septum
with distinct separation of true and false lumens, prohibit-
ing an adequate proximal stent graft landing zone at the
intrarenal aortic neck. True and false lumens were accessed,
and an endovascular septectomy was performed across a
fenestration at the level of the infrarenal aortic neck to
create an adequate proximal stent graft landing zone for
successful EVAR. Patient subsequently presented with jux-
tarenal 7.8 cm AAA with a true lumen pedicle perfusing all
visceral vessels. Patient underwent TEVAR bridging the
thoracic and abdominal aortic stent grafts and a chimney
to the pedicle perfusing all visceral vessels, and complete
aneurysm exclusion. At 1 year postoperatively, patient is
doing well, with complete thoracoabdominal aortic aneu-
rysms exclusion.
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Objectives: Previous studies have proven the feasibility
of performing a pancreaticoduodenectomy (Whipple) in pa-
tients with portal veinn/superior mesenteric vein (PV/
SMV) or arterial invasion. We report our institutional expe-
rience with the use of a variety of vascular reconstructive
methods during pancreatic resections for adenocarcinoma.
Methods: A retrospective review was performed iden-
tifying all Whipple and total pancreatectomy patients from
January 2003 through February 2013. All venous (PV/
SMV) and arterial (SMA/hepatic) reconstructions were
extracted and reviewed to determine survival and perioper-
ative complications.
Results: During the 10-year study period, 270 Whip-
ple and total pancreatectomy procedures were performed,
of which 183 were for adenocarcinoma of the pancreas.
A total of 60 of 183 (32.8%) vascular reconstructions
were found, 49 venous and 11 arterial. Venous reconstruc-
tion included 37 (61.7%) primary repairs, 4 (6.7%) recon-
structions with cryovein, 3 (5.0%) repairs with autologous
vein patch, 3 (5.0%) autologous saphenous reconstruc-
tions, and 2 (3.33%) portocaval shunts. Additionally, there
were 11 (18.3%) arterial reconstructions (seven hepatic ar-
tery and four superior mesenteric artery). There was one
perioperative death (1.7%). One-year survival for all recon-
structions was 70.3%, which is equivalent to T3 lesions that
did not receive vascular reconstruction (72.6%), with a me-
dian survival time of 515 days and 12 patients still alive.
Survival time was comparable with each type of venous
reconstruction, averaging 528 days (11 of 49 patients still
alive). Of the venous reconstructions, four of 49 (8.2%)
resulted in PV thrombosis, three within the primary repair
group and one delayed thrombosis within the cryovein
group. There was no thrombosis in any patients after arte-
rial reconstruction.
Conclusions: An aggressive approach for stage II
pancreatic cancers with venous or arterial invasion can be
performed with comparable results when executed by an
experienced institution with skilled oncologic and vascular
surgeons.
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